Rho GTPases, which control processes such as cell proliferation and cytoskeleton remodeling, are often hyper-expressed in tumors. Several members, such as RhoA/B/C, must be isoprenylated to interact with their effectors. Statins, by inhibiting the synthesis of prenyl groups, may affect RhoA/B/C activity and represent a promising tool in anticancer therapy.
Statins-mediated inhibition of rho GTPases as a potential tool in anti-tumor therapy
RIGANTI, Chiara;ALDIERI, Elisabetta;DOUBLIER, Sophie Michelle;BOSIA, Amalia;GHIGO, Dario Antonio
2008-01-01
Abstract
Rho GTPases, which control processes such as cell proliferation and cytoskeleton remodeling, are often hyper-expressed in tumors. Several members, such as RhoA/B/C, must be isoprenylated to interact with their effectors. Statins, by inhibiting the synthesis of prenyl groups, may affect RhoA/B/C activity and represent a promising tool in anticancer therapy.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Riganti, Mini Rev Med Chem, 2008.pdf
Accesso riservato
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
299.69 kB
Formato
Adobe PDF
|
299.69 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
